Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Pathology|December 9, 2023
Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryWei Yang Ng, Wendy N Erber, Andrew Grigg, et al.
Internal Medicine Journal|March 6, 2017
A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisP Joy Ho, Ashish Bajel, Kate Burbury, et al.
Targeted Oncology|November 12, 2020
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Targeted Oncology|October 12, 2020
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Leukemia & Lymphoma|July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaGenevieve Douglas, Claire Harrison, Cecily Forsyth, et al.
BMC Cancer|July 11, 2024
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in AustraliaSimon Fifer, Jenni Godsell, Stephen Opat, et al.
European Journal of Haematology|September 15, 2023
Long-term effectiveness of eculizumab: Data from the International PNH RegistryLouis Terriou, Jong Wook Lee, Cecily Forsyth, et al.
Blood|June 20, 2012
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortPeter J Campbell, Cathy MacLean, Philip A Beer, et al.
Leukemia & Lymphoma|September 13, 2019
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationMaansi Joshi, John Taper, Cecily Forsyth, et al.
British Journal of Haematology|October 2, 2014
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaAshish Banerjee, Nicole A Mifsud, Robert Bird, et al.
Pageof 4